Disc Medicine CEO John Quisel sells $2.6m in shares By Investing.com

Disc Medicine CEO and director John D. Quisel sold 33,000 shares of the company’s common stock on August 17, 2026 for $2,611,982, according to the reported transactions. The sales were carried out under a Rule 10b5-1 trading plan adopted March 12, 2026, with weighted average prices ranging from $78.1061 to $79.842 across multiple trades. On the same date, Quisel acquired 33,000 shares by exercising stock options at $13.50 per share for $445,500. Afterward, he directly held 226,064 shares and also held 91,586 stock options. The stock last traded at $80.20, up 38% over the prior year.